IR-Med Dividend

Dividend criteriumcontroles 0/6

IR-Med does not have a record of paying a dividend.

Belangrijke informatie

n/a

Dividendrendement

-2.0%

Terugkoop Rendement

Totaal aandeelhoudersrendement	-2.0%
Toekomstig dividendrendement	n/a
Dividendgroei	n/a
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	n/a
Uitbetalingsratio	n/a

Recente dividendupdates

Geen updates

Recent updates

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Insufficient data to determine if IRME's dividends per share have been stable in the past.

Groeiend dividend: Insufficient data to determine if IRME's dividend payments have been increasing.

Dividendrendement versus markt

IR-Med Dividendrendement versus markt

Hoe verhoudt IRME dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (IRME)	n/a
Markt onderkant 25% (US)	1.5%
Markt Top 25% (US)	4.5%
Gemiddelde industrie (Medical Equipment)	1.7%
Analist prognose (IRME) (tot 3 jaar)	n/a

Opmerkelijk dividend: Unable to evaluate IRME's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Hoog dividend: Unable to evaluate IRME's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Winstuitkering aan aandeelhouders

Verdiendekking: Insufficient data to calculate IRME's payout ratio to determine if its dividend payments are covered by earnings.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Unable to calculate sustainability of dividends as IRME has not reported any payouts.

IR-Med Dividend

Dividend criteriumcontroles 0/6

Belangrijke informatie

Recente dividendupdates

Recent updates

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers

IR-Med Inc. has filed an IPO in the amount of $8 million.

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc.’s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Hmo

IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

Ir-Med Inc. Announces Interim Results from A Clinical Study of Pressuresafe

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

IR-Med Inc., Annual General Meeting, Dec 12, 2022

IR-Med Announces Appointment of Moshe Gerber as Chief Executive Officer

International Display Advertising, Inc. (OTCPK:IDAD.D) completed the acquisition of IR Med, Ltd.

International Display Advertising, Inc. announced that it expects to receive $5 million in funding

Stabiliteit en groei van betalingen

Dividendrendement versus markt

Winstuitkering aan aandeelhouders

Contante uitbetaling aan aandeelhouders

Ontdek bedrijven met een sterk dividend